and Resonea Inc, a breathing frequency monitor deployed on a mobile phone for prescreening adults with suspected obstructive sleep apnea, have partnered to offer obstructive sleep apnea (OSA) screening services and equipment.

“We strive to give our customers top-rated products from trusted brands at competitive prices, and exceptional care,” says Lauren Bennet, vice president of sales operations at, in a release. “Being able to offer OSA screening to our clients that they can do from their smartphone is a game changer for us. It means our customers will now have a highly reliable and accurate one-stop-shop for all of their sleep apnea assessment and treatment needs.”

Under the new partnership, will offer Resonea’s DROWZLE sleep apnea screening at no charge. Users can then purchase DROWZLE PRO, a US Food and Drug Administration-cleared prescription, class II medical device that consists of smartphone-based software that records and analyzes respiratory patterns during sleep for the purpose of in-home screening for OSA. Results are used to assist healthcare professionals in determining the need for additional diagnosis and evaluation

“Partnering with allows us to offer an end-to-end solution for patients suffering from sleep apnea,” says Karen Underwood, MD, chief medical officer at Resonea, in a release. “Eighty percent of people with sleep apnea never get diagnosed. This partnership allows more people to screen themselves in the privacy of their own home and take the next steps to testing and treatment.”